{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:48:49Z","timestamp":1789220929474,"version":"build-2803163510"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T00:00:00Z","timestamp":1363824000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002130","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T20:54:44Z","timestamp":1363899284000},"page":"e2130","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":97,"title":["Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis"],"prefix":"10.1371","volume":"7","author":[{"given":"Piero","family":"Olliaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Arana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Grogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrokh","family":"Modabber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Magill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lapujade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,21]]},"reference":[{"key":"ref1","first-page":"CD004834","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","author":"U Gonzalez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","first-page":"CD005067","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"U Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/655134","article-title":"Designing and reporting clinical trials on treatments for cutaneous leishmaniasis","volume":"51","author":"U Gonzalez","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref4","unstructured":"Lang T, Cheah PY, Hien TT, Chilengi R, Collaborators in Global Health Clinical Trials.org (2009) Global Health Clinical Trials Programme. Available: http:\/\/globalhealthtrials.tghn.org\/<\/ext-link> Accessed 29 January 2013."},{"key":"ref5","unstructured":"The SUPPORT Project (Supporting Policy relevant Reviews and Trials) (2001) Trial Protocol tool. Available http:\/\/globalhealthtrials.tghn.org\/site_media\/media\/articles\/trialprotocoltool\/TrialProtocolTool.html<\/ext-link> Accessed 29 January 2013."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"RE Saenz","year":"1990","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-126-3-199702010-00010","article-title":"Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial","volume":"126","author":"I Velez","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/165.3.518","article-title":"The natural history of cutaneous leishmaniasis in Guatemala","volume":"165","author":"BL Herwaldt","year":"1992","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"BA Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"TR Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4269\/ajtmh.1991.45.92","article-title":"Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis","volume":"45","author":"RH Guderian","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"ref12","unstructured":"World Health Organization W (2010) Control of the Leishmaniasis. Report of a meeting of the WHO Expert Committee on the Control of the Leishmaniases. Geneva: WHO Technical Report Series."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species","volume":"64","author":"R Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate","volume":"195","author":"A Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"ref15","unstructured":"Fernandez Olmos A, Diaz YR, Ovalle C, Muvdi S, Valderrama L, et al<\/etal>.. Drug susceptibility of Leishmania vianna species in Colombia; 2011. 60th congress of the American Society of Tropical Medicine and Hygiene; Dec 4\u20138, 2011; Philadelphia, Pennsylvania, United States."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0035-9203(91)90026-U","article-title":"A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis","volume":"85","author":"G Harms","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-4632.2009.04099.x","article-title":"Immunohistochemistry and polymerase chain reaction on paraffin-embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon region","volume":"48","author":"VS Amato","year":"2009","journal-title":"Int J Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.2010.09-0414","article-title":"Clinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis","volume":"83","author":"AK Boggild","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","first-page":"1","article-title":"Comparison of three methods for diagnosis of cutaneous leishmaniasis","volume":"5","author":"B Pourmohammadi","year":"2010","journal-title":"Iran J Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00436-008-1111-4","article-title":"Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods","volume":"103","author":"F Shahbazi","year":"2008","journal-title":"Parasitol Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"J Arevalo","year":"2007","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"R Rojas","year":"2006","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"J Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref24","unstructured":"National Cancer Institute (2010) Common Toxicity Criteria Version 3. Available http:\/\/ctep.cancer.gov\/protocolDevlopement\/electronic_applications\/ctc.htm<\/ext-link> Accessed 29 January 2013."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism. The CAGE questionnaire","volume":"252","author":"JA Ewing","year":"1984","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4269\/ajtmh.1985.34.856","article-title":"American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules","volume":"34","author":"CN Oster","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","article-title":"Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis","volume":"2","author":"WR Ballou","year":"1987","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"A Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"TR Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"ref30","unstructured":"International Conference on Harmonisation, editor (2000) Clinical Safety Data Management: Definitions and Standards for Expedited Reporting."},{"key":"ref31","unstructured":"European Medicines Agency (EMA), editor (2000) ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting Step 5 (CPMP\/ICH\/377\/95) www.ema.europa.eu<\/ext-link>."},{"key":"ref32","unstructured":"Food and Drug Administration (2011) Reporting Serious Problems to FDA: What is a Serious Adverse Event? Available http:\/\/www.fda.gov\/safety\/medwatch\/howtoreport\/ucm053087.htm<\/ext-link> Accessed 29 Jannuary 2013."},{"key":"ref33","unstructured":"International Conference on Harmonisation (2013) Efficacy Guidelines. Available http:\/\/www.ich.org\/products\/guidelines\/efficacy\/article\/efficacy-guidelines.html<\/ext-link> Accessed 29 January 2013."},{"key":"ref34","unstructured":"World Health Organization (WHO) (2010) ICD-10 Version:2010. Available: http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en<\/ext-link>."},{"key":"ref35","unstructured":"National Cancer Institute (2010) NCI Common Terminology Criteria for Adverse Events (CTCAE) v.4 data files Available http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html<\/ext-link> Accessed 29 January 2013."},{"key":"ref36","unstructured":"National Institute of Allergies and Infectious Diseases (2011) DMID Clinical Research Policies and Standard Procedure Documents. Available http:\/\/www.niaid.nih.gov\/LabsAndResources\/resources\/DMIDClinRsrch\/pages\/toxtables.aspx<\/ext-link> Accessed 29 January 2013."},{"key":"ref37","unstructured":"International Conference on Harmonisation, editor (2000) ICH harmonised tripartite guideline: choice of control group and related issues in clinical trials. Available: http:\/\/www.ich.org\/products\/guidelines\/efficacy\/efficacy-single\/article\/choice-of-control-group-and-related-issues-in-clinical-trials.html<\/ext-link>."},{"key":"ref38","first-page":"40","article-title":"The misunderstood placebo","volume":"10","author":"S Senn","year":"2001","journal-title":"applied clinical trials"},{"key":"ref39","unstructured":"Chow SC, Liu JP (2004) Hypotheses testing and p-values. In: Design and analysis of clinical trials Concept and methodologies. second edition ed: Wiley & Sons. pp. 72\u201373."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/sim.1425","article-title":"Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics","volume":"22","author":"RB D'Agostino Sr","year":"2003","journal-title":"Stat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/CVM-1-1-019","article-title":"Noninferiority trials","volume":"1","author":"SM Snapinn","year":"2000","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"S Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"895; author reply 896\u2013897","DOI":"10.1016\/S0140-6736(08)60406-7","article-title":"The ethics of non-inferiority trials","volume":"371","author":"EZ Soliman","year":"2008","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/sim.1400","article-title":"Design and analysis of non-inferiority mortality trials in oncology","volume":"22","author":"M Rothmann","year":"2003","journal-title":"Stat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/009286150103500212","article-title":"Statistical methods for comparison to placebo in active control trials","volume":"35","author":"V Hasselblad","year":"2001","journal-title":"Drug Information Journal"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"c2697","DOI":"10.1136\/bmj.c2697","article-title":"Modified intention to treat reporting in randomised controlled trials: systematic review","volume":"340","author":"I Abraha","year":"2010","journal-title":"BMJ"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/sim.1360","article-title":"Therapeutic equivalence: fallacies and falsification","volume":"22","author":"AD Garrett","year":"2003","journal-title":"Stat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1467-9884.00227","article-title":"Consensus and controversy in pharmaceutical statistics","volume":"49","author":"S Senn","year":"2000","journal-title":"Journal of the Royal Statistical Society Series D (The Statistician)"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"B Jones","year":"1996","journal-title":"BMJ"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/sim.1934","article-title":"A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials","volume":"24","author":"E Brittain","year":"2005","journal-title":"Stat Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement","volume":"295","author":"G Piaggio","year":"2006","journal-title":"JAMA"},{"key":"ref53","first-page":"3137","article-title":"[Noninferiority and equivalence randomized trials: lessons and reservations\u2013secondary publication]","volume":"168","author":"PC Gotzsche","year":"2006","journal-title":"Ugeskr Laeger"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/sim.2230","article-title":"The effects of non-compliance on intent-to-treat analysis of equivalence trials","volume":"25","author":"D Sheng","year":"2006","journal-title":"Stat Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/sim.2244","article-title":"Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat","volume":"25","author":"M Matilde Sanchez","year":"2006","journal-title":"Stat Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/sim.4780131209","article-title":"Confidence-Intervals for a Binomial Proportion","volume":"13","author":"RG Newcombe","year":"1995","journal-title":"Statistics in medicine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2307\/2530822","article-title":"Group sequential clinical trials with triangular continuation regions","volume":"39","author":"J Whitehead","year":"1983","journal-title":"Biometrics"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"AA Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"A Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/biomet\/83.4.934","article-title":"A unifying approach for confidence intervals and testing of equivalence and difference","volume":"83","author":"M Bauer","year":"1996","journal-title":"Biometrika"},{"key":"ref62","unstructured":"Committee for Proprietary Medicinal Products (2000) Points to consider on switching between superiority and non-inferiority. London: European Medicine Agency (EMA)."},{"key":"ref63","unstructured":"Consolidated Standards of Reporting Trials (2001) Available: http:\/\/www.consort-statement.org\/<\/ext-link>. Available."},{"key":"ref64","unstructured":"International Conference on Harmonization (1996) ICH E6 R1 Guideline. Available http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf<\/ext-link> Accessed 29 January 2013."},{"key":"ref65","unstructured":"World Health Organization (WHO) (2005) Who Handbook for Good Clinical Practice (GCP): guidance for implementation. Available: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2465715\/<\/ext-link>."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1365-3156.2006.01765.x","article-title":"Editorial: clinical trials in tropical diseases: a politically incorrect view","volume":"11","author":"NJ White","year":"2006","journal-title":"Trop Med Int Health"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:40:17Z","timestamp":1588995617000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002130"}},"subtitle":[],"editor":[{"given":"Mehmet Ali","family":"Ozcel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,21]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002130","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,21]]}}}